Accessibility StatementSkip Navigation MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. SOURCE Lifeway Foods, Inc. 21% more press release views with Request a Demo Also from this source Lifeway Foods Awarded on TI ...

Accessibility StatementSkip Navigation Leading kefir company ranks 33 overall and 2 among Food & Beverage companies MORTON GROVE, Ill., Nov. 3, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, is proud to announce its inclusion in the America's Growth Leaders 2026 list, a distinguished ranking honoring companies demonstrating exceptional growth performance, financial sta ...

Lifeway Foods’ decision to extend its shareholder rights plan has drawn criticism from investor Edward Smolyansky, who called the move a “shield for management”. The US kefir producer's board has approved a one-year extension to the rights plan to 29 October 2026, leaving all other terms unchanged. Lifeway adopted the limited duration rights plan in November last year after turning down takeover interest from Danone. Mr. Smolyansky, the brother of Lifeway CEO Julie Smolyansky, said the move was the “mos ...

Accessibility StatementSkip Navigation MORTON GROVE, Ill., Oct. 29, 2025 /PRNewswire/ --Lifeway Foods, Inc. (Nasdaq: LWAY) ("Lifeway" or the "Company"), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, today announced that its Board of Directors has approved an amendment to the Company's existing Shareholder Rights Agreement (the "Rights Plan") to extend its expiration date for one year. All other terms and conditions of the Rights Plan remain unchanged. Furth ...

诉讼纠纷与和解协议 - 达能同意暂停对Lifeway Foods的诉讼并投票支持其董事会，双方达成全面协议[1] - 达能此前因反对Lifeway向CEO发行新股而提起诉讼，Lifeway反诉达能主张无效[2] - 根据新协议，双方同意暂停与此事相关的所有相互诉讼[2] Lifeway公司治理变动 - Lifeway同意任命四位与达能、Lifeway或CEO家族无关的新独立董事[3] - 新董事任命需经达能善意审查后批准[3] - 作为协议一部分，Lifeway两名任职时间最长的董事会成员将离职[4] - Lifeway计划分离董事长和CEO角色，CEO Julie Smolyansky留任，未来由独立董事担任董事长[4] 达能的承诺与战略评估 - 达能同意在Lifeway 2025年和2026年股东年会上投票支持其董事会[4] - 达能在SEC文件中重申正在持续评估其对Lifeway的投资，包括可能出售部分或全部持股[5] - 达能于上月宣布不再寻求收购Lifeway Foods，据报因认为两家公司无法有效合作[6] 管理层表态 - Lifeway CEO表示协议为公司带来清晰度和稳定性，使公司能专注于扩大益生菌食品市场和为股东创造价值[5]

Lifeway Foods can “move forward with clarity and stability”, the kefir maker’s CEO has said, after the company struck a “co-operation” deal with minority shareholder Danone. The relationship between Lifeway and Danone – which invested in the business in 1999 – has become strained over the last 12 months after the US group rejected two takeover bids from the French giant and the companies embarked on litigation against each other. This summer, “representatives” of Danone and Lifeway started talks to “rese ...

公司与主要股东达成合作协议 - Lifeway Foods与Danone North America达成合作协议，内容包括董事会有序改组、暂停相关诉讼以及Danone不支持由Edward和Ludmila Smolyansky等人发起的同意征求书中的提案 [1] 董事会改组安排 - 公司同意在2025年10月30日前任命三位符合纳斯达克规则且独立的董事，并在2025年11月14日前再任命一位独立董事，这些董事由董事会战略评估委员会选定，且与Danone、Smolyansky家族及公司现任高管或董事无关联 [4] - 为促进良好治理并保持董事会连续性，Pol Sikar将在2025年股东年会前卸任董事，Jay Scher和另一位现任董事将在2026年股东年会前卸任 [4] - 公司同意在2025年10月30日或第三位新独立董事任命之日（以较早者为准）前，将董事长与CEO角色分离，并任命一位独立董事担任董事长，Julie Smolyansky将继续担任CEO [4] 诉讼与股东协议处理 - Lifeway和Danone同意共同暂停未决的诉讼 [4] - 公司同意遵守与Danone的股东协议，不再质疑其有效性，Danone则同意放弃协议中的某些权利，包括其任命董事会成员的权利 [4] - 如果Danone及其关联方不再持有至少相当于当前已发行普通股5%的股份，Danone同意放弃并不再执行其在股东协议下的权利（账簿和记录权除外） [4] Danone对股东行动的支持立场 - 在2026年6月30日之前的任何时间，如果Edward或Ludmila Smolyansky要求召开特别股东大会或发起同意征求，Danone将根据董事会的建议，就所有与董事会组成相关的事项以及（除某些例外情况外）Lifeway的组织文件相关事项进行投票或提交同意书 [4] 股权激励与注册声明 - 公司薪酬委员会被允许向除Julie Smolyansky及其亲属以外的管理层成员授予股权激励，以使公司能够像其他上市公司一样吸引和留住人才 [4] - 公司同意在2025年10月30日前提交储架注册声明，以便为Danone可能出售其持有的Lifeway普通股进行公开发行注册，Danone同意，如果决定出售其股份，将善意考虑对其全部或部分股份进行潜在的市场化发行 [4] 公司战略与资本配置评估 - 鉴于上述变化，公司正在评估资本配置方案，以最大化股东价值 [3] - 公司CEO表示，该协议为公司带来了清晰度和稳定性，使公司能够继续专注于将富含益生菌的食品带给更多家庭并为股东创造价值 [5] 公司业务概况 - Lifeway Foods是美国领先的开菲尔和发酵益生菌产品供应商，其产品支持微生物组健康，除饮用型开菲尔外，还生产各种奶酪和面向儿童的ProBugs®产品线，产品在美国、墨西哥、爱尔兰、南非、阿联酋和法国销售 [7]

公司扩张计划 - 宣布一项数百万美元的投资计划 旨在将威斯康星州沃基沙市的开菲尔产品产能提升一倍 [1] - 产能扩张项目的第一阶段已完成 整个项目预计于2026年第三季度完工 [1] 产能提升进展 - 截至今年 公司用于将原料奶与活性开菲尔菌种混合的发酵罐数量已增加一倍 [2] 财务业绩表现 - 第三季度前两个月未经审计的净销售额为3910万美元 较去年同期增长20% [3] - 公司已实现连续22个季度的增长 [3] 增长驱动因素 - 开菲尔产品（包括牛奶和冰沙）受益于消费者对便捷、营养密集食品的需求增长 [2] - 使用GLP-1减肥药物的消费者转向酸奶和乳制品以增加蛋白质摄入 [2] - 与Target、Whole Foods、Amazon Fresh等零售商达成的扩大分销协议促进了增长 [3] 战略定位与影响 - 扩张计划旨在确保公司智能扩张、投资社区并保持在功能性乳品创新领域的领先地位 [4] - 公司每年使用约1亿磅来自威斯康星州的牛奶生产开菲尔 新投资将对当地乳业经济产生积极影响 [4] 公司近期背景 - 此前乳业巨头达能两次尝试收购未果后已放弃收购计划 公司表示将专注于执行其增长战略 [5]

Danone has abandoned its pursuit of acquiring Lifeway Foods and is exploring its options for its investment in the US kefir maker. Last month, Danone and Lifeway signed an NDA to allow the French giant to weigh up whether to make another bid for Lifeway after having two offers turned down. According to an SEC filing yesterday (18 September), Danone has decided against a fresh bid and is weighing alternatives that includes “selling all or part” of its approximately 22.7% stake in Lifeway. In response, Li ...

Lifeway Foods (NASDAQ:LWAY) shares fell 25% premarket on Thursday following Danone's (OTCQX:DANOY) withdrawal of its proposal to acquire the company. In 2024, Lifeway, which supplies kefir and fermented probiotic products, received a proposal from Danone (OTCQX:DANOY) to purchase the ...